Banane, Charles Joel G.
HRN: 23-96-58 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/17/2024
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
01/17/2024
01/24/2024
IV
75mg
Q24H
PCAP C
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes